SBF1P1

Across TCGA pan-cancer cohorts, SBF1P1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated SBF1P1 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher SBF1P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SBF1P1 expression acts as an unfavorable survival marker, although some lineages such as ESCA and HNSC show a favorable association.

LIHC, LUSC, and ESCA are the cancer types where SBF1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.335	0.563	<.001	90	view →
LUSC	OS	Tertile	III,IV	0.514	0.760	.006	64	view →
ESCA	OS	Median	II,III,IV	0.570	0.362	.003	52	view →
LUAD	DFS	Quartile	IV	0.081	0.632	<.001	46	view →
HNSC	OS	Tertile	II,III,IV	0.626	0.336	.006	35	view →
BRCA	DFS	Quartile	All	0.858	0.911	.008	31	view →
READ	OS	Median	All	1.000	0.431	.001	31	view →
UVM	OS	Tertile	All	0.685	0.860	.023	30	view →
SKCM	DFS	Tertile	II,III,IV	0.359	0.209	.004	27	view →
MESO	OS	Tertile	III,IV	0.137	0.593	.007	27	view →
LGG	OS	Tertile	All	0.510	0.340	.003	23	view →
PRAD	DFS	Tertile	All	0.948	0.860	.003	22	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

SBF1P1–LIHC (DFS)

Open the LIHC breakdown →